MedWatch

Analyst: Pentax partnership might lead Ambu to new market

The recently announced Pentax/Jiangsu Vedkang partnership also includes the sale of Vedkang's tools for endoscopes, which may inspire Ambu to enter this market, analysts say.

Juan Jose Gonzales, CEO of Ambu | Photo: Ambu/PR

Medtech company Ambu has many good reasons to keep an eye on its competitor, Pentax, and its recently established partnership with Jiangsu Vedkang.

The new alliance demonstrates the increasing competition within single-use endoscopes and highlights another growing tendency.

Already a subscriber? Log in.

Read the whole article

Get access for 14 days for free.
No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.

  • Access all locked articles
  • Receive our daily newsletters
  • Access our app
An error has occured. Please try again later.

Get full access for you and your coworkers.

Start a free company trial today

More from MedWatch

Further reading

Related articles

Latest news

See all jobs